best glp-1 for kidney disease Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Disease: A Narrative Review of the Key Evidence with Practical Considerations | Diabetes Therapy Popular GLP-1 medications may have

Vadala G, Sowa GA, Kang JD: Gene therapy for disc degeneration

Cancer 72 (1), 7487

While some of the warnings have changed over the last few years and and to some degree gotten better in the United States, said Jonathan Orent, a lead plaintiffs attorney with Motley Rice in the multidistrict litigation overseen by a federal court in Philadelphia, we think that the full panoply of conditions that this set of drugs can cause are not fully warned of, and until that happens, people are continuing to get hurt without having the full information. Some of the plaintiffs who spoke to USA TODAY said they hope to see stronger or more specific warnings about the potential for severe outcomes

10.1038/s41380-018-0237-8 117